Phase 1/2 study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
Phase of Trial: Phase I/II
Latest Information Update: 19 Jan 2010
At a glance
- Drugs Enzastaurin; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2010 Actual end ate added as Dec 2009 reported by as reported by ClinicalTrials.gov.
- 19 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Nov 2008 Status changed from recruiting to active, no longer recruiting, as reported in ClinicalTrials.gov.